Journal of Pain and Symptom Management
Volume 38, Issue 4 , Pages 515-521 , October 2009

Frequency of Long-Acting Opioid Analgesic Initiation in Opioid-Naïve Nursing Home Residents

  • David M. Dosa, MD, MPH

      Affiliations

    • Center for Gerontology and Health Care Research, The Warren Alpert Medical School at Brown University, Providence, Rhode Island, USA
    • Veterans Administration Medical Center, Rhode Island Hospital, Providence, Rhode Island, USA
    • Division of Geriatrics, Rhode Island Hospital, Providence, Rhode Island, USA
    • Corresponding Author InformationAddress correspondence to: David Dosa, MD, MPH, Division of Geriatrics, Brown University, Rhode Island Hospital, 593 Eddy Street, APC 424, Providence, RI 02903, USA.
    • ,
  • David D. Dore, PharmD, PhD

      Affiliations

    • Department of Community Health, The Warren Alpert Medical School at Brown University, Providence, Rhode Island, USA
    • i3 Drug Safety, Waltham, Massachusetts, USA
    • ,
  • Vincent Mor, PhD

      Affiliations

    • Center for Gerontology and Health Care Research, The Warren Alpert Medical School at Brown University, Providence, Rhode Island, USA
    • Department of Community Health, The Warren Alpert Medical School at Brown University, Providence, Rhode Island, USA
    • ,
  • Joan M. Teno, MD, MS

      Affiliations

    • Center for Gerontology and Health Care Research, The Warren Alpert Medical School at Brown University, Providence, Rhode Island, USA
    • Department of Community Health, The Warren Alpert Medical School at Brown University, Providence, Rhode Island, USA
    • Division of Geriatrics, Rhode Island Hospital, Providence, Rhode Island, USA

,Accepted 10 December 2008.

  • Image Result

    Cohort selection criteria. LAO=Long-acting opioids including transdermal fentanyl, morphine sulfate controlled release, and oxycodone controlled release; MDS=minimum data set.

    Cohort selection criteria. LAO=Long-acting opioids including transdermal fentanyl, morphine sulfate controlled release, and oxycodone controlled release; MDS=minimum data set.

 This work was supported by grant number 5T32HS000011-21 from the Agency for Health Care Research and Quality (PI Dr. Mor, Dr. Dore supported).Dr. Dore conducted this work while an employee of Brown University and, during this time, received consultancy fees from Pfizer, Inc. and i3 Drug Safety for work independent of this study. Drs. Dosa, Mor, and Teno have no disclosures to report.Dr. Dore had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The sponsor had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the article.

PII: S0885-3924(09)00306-6

doi: 10.1016/j.jpainsymman.2008.11.008

Journal of Pain and Symptom Management
Volume 38, Issue 4 , Pages 515-521 , October 2009

Article Tools

* Image Usage & Resolution